Business
HYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German Market
VANCOUVER, British Columbia, March 28, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has entered into strategic supply agreements (the “Agreements”) and successfully completed vendor qualification with two cannabis cultivators under its Good Manufacturing Practice (GMP) system qualifying a minimum of 4000 kg of cannabis for the German market. This
About this update from Hytn Innovations Inc
[{"type":"image","alt":"HYTN Innovations Inc.","displaySize":"","headline":null,"caption":"HYTN Innovations Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":267,"height":91,"url":"https://media.zenfs.com/en/globenewswire.com/d0d2c55d487605e813bedcd12be5d8b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/F4ytl8DbwvMmCVotlu1mBA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/d0d2c55d487605e813bedcd12be5d8b1","width":267,"height":91}},"lazy":false},{"type":"text","content":"VANCOUVER, British Columbia, March 28, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has entered into strategic supply agreements (the “Agreements”) and successfully completed vendor qualification with two cannabis cultivators under its Good Manufacturing Practice (GMP) system qualifying a minimum of 4000 kg of cannabis for the German market. This milestone builds on HYTN’s recent announcements outlining its strategic transition into international pharmaceutical sales, including partnerships with SNDL Inc (SNDL) and 4C Labs, and further strengthens its manufacturing scope, positioning the Company for continued global expansion.","length":806,"tagName":"p"},{"type":"text","content":"The Agreements, which were entered into in February 2025, were subject to HYTN’s rigorous qualification process through which the Company conducted comprehensive site audits, quality control evaluations, and verified compliance with Good Agricultural and Collection Practices (GACP) to ensure alignment with German pharmacopeia standards. These Agreements establish strict product specifications, testing protocols, and pricing structures, ensuring compliance with stringent microbiological limits and non-irradiation requirements while securing a reliable and consistent cannabis supply for Germany. The two cultivators which have been qualified in HYTN’s system for the German market are Klonetics Plant Science Inc. and another Kelowna company which has requested non-disclosure.","length":782,"tagName":"p"},{"type":"text","content":"With qualification complete, the approved cultivators will commence production, focusing on high-potency cultivars specifically tailored f...